Biocon Reports Q4 FY24 Earnings with 12% Revenue Growth in Biosimilars June 27, 2024, 6:40 p.m. Biocon Limited has released its Q4 FY24 Investor Presentation, highlighting key financial and operational metrics.Total revenue for FY24 stood at ₹15,621 Crores, a 35% increase from … Unlock the Full Filing And Lot More Access premium insights and stay ahead of the market with Dzambhala Pro. Learn More